Avadel Pharmaceuticals Plc

Ownership Transactions Reported by 11 Insiders

Symbol: AVDL on Nasdaq
Industry: Pharmaceutical Preparations
Location: Block 10 1 Blanchardstown Corporate Park, Ballycoolin, Dublin, Ireland

Insiders trading volume in the past year

	Insiders	Shares	%	Avg Price	Total $
Buys	6	+85.6K	100%	$8.90	+$762K
Sells	0
Net	+6	+85.6K	100%		+$762K

Avadel Pharmaceuticals Plc executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Thomas S. Mchugh	Chief Financial Officer	$2.08M	+$76.5K	+3.81%	Dec 13, 2024
Mark Anthony McCamish	Director	$1.77M			Jul 30, 2024
Gregory J. Divis	Chief Executive Officer, Director	$1.66M	+$99.7K	+6.4%	Dec 6, 2024
Eric J. Ende	Director	$1.64M	+$235K	+16.8%	Jan 13, 2025
Geoffrey Michael Glass	Director	$852K	+$200K	+30.6%	Dec 10, 2024
Peter J. Thornton	Director	$837K	+$80.5K	+10.6%	Jan 13, 2025
Linda Palczuk	Director	$538K	+$70.2K	+15%	Jan 21, 2025
Naseem Amin	Director	$112K			Jul 30, 2024
Jerad G. Seurer	Gen. Counsel & Corp. Secretary	$89.6K			Apr 30, 2024
Douglas J. Williamson	Chief Medical Officer				Feb 14, 2022
Richard J. Kim	Chief Commercial Officer				Feb 20, 2024

Recent Insider Transactions by Companies or Individuals for Avadel Pharmaceuticals Plc

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.